HDAC11 and metabolic dysfunction-associated steatotic liver disease: Previous study has indicated HDAC11‐deficient mice exhibit enhanced thermogenic capacity and reduced obesity, further supporting the therapeutic potential of HDAC11 inhibition.[16] In this study, we examined the role of HDAC11 in MASLD.